Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 108
Titolo Data di pubblicazione Autore(i) File
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. 2005 Rossini F;Terruzzi E;Verga L;Larocca A;Marinoni S;Miccolis I;Giltri G;Isella M;Parma M;Pogliani EM
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. 2006 Larocca A;Piaggio G;Podestà M;Pitto A;Bruno B;Di Grazia C;Gualandi F;Occhini D;Raiola AM;Dominietto A;Bregante S;Lamparelli T;Tedone E;Oneto R;Frassoni F;Van Lint MT;Pogliani E;Bacigalupo A
Bortezomib, Pegylated-Lyposomal-Doxorubicin and Dexamethasone Followed by Melphalan 100 mg/m2 in Elderly Newly Diagnosed Patients: An Interim Analysis. 2007 Palumbo A; Avonto I; Patriarca F; Crippa C; Petrucci MT; Rossini F; Corradini P; Liberati AM; Giuliani N; Pescosta N; Falco P; Larocca A; Omedè P; Offidani M; Fanin R; Boccadoro M
Gammopatie monoclonali 2008 Mario Boccadoro, Francesca Gay, Alessandra Larocca, Valeria Magarotto, Antonio Palumbo
Defibrotide: a review on clinical use and future development. 2008 Larocca A;Cavallo F;Magarotto V;Rossi D;Patriarca F;Boccadoro M;Palumbo A
Treatment of newly diagnosed multiple myeloma. 2008 Palumbo A;Magarotto V;Larocca A;Bringhen S;Falco P;Di Raimondo F;Baldini L;Boccadoro M
Lenalidomide and its role in the management of multiple myeloma 2008 Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Melphalan, prednisone, and lenalidomide for newly diagnosed myeloma: kinetics of neutropenia and thrombocytopenia and time-to-event results 2009 Palumbo A; Falco P; Falcone A; Benevolo G; Canepa L; Gay F; Larocca A; Magarotto V; Gozzetti A; Luraschi A; Morabito F; Nozza A; Knight RD; Zeldis JB; Boccadoro M; Petrucci MT.
ACHIEVEMENT OF COMPLETE REMISSION IS A STRONG PROGNOSTIC FACTOR IN 895 ELDERLY MYELOMA PATIENTS TREATED WITH MELPHALAN-PREDNISONE BASED-REGIMENS: RESULTS OF 3 MULTICENTER ITALIAN TRIALS 2010 F Gay; A Larocca; MT Petrucci; P Musto; AM Liberati; V Callea; R Ria; T Caravita; C Cangialosi; M Grasso; M Offidani; P Pregno; F Patriarca; M Galli; M Cavo; L Catalano; C Nozzoli; T Guglielmelli; R Zambello; F Pisani; V Montefusco; F Rossini; V De Stefano; B Lupo; F Di Raimondo; G Gaidano; M Boccadoro; A Palumbo
Lenalidomide, melphalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma. 2010 Palumbo A;Larocca A;Falco P;Sanpaolo G;Falcone AP;Federico V;Canepa L;Crugnola M;Genuardi M;Magarotto V;Petrucci MT;Boccadoro M
High Expression of mRNA and Gene Amplification of Met In Myeloma Plasma Cells Characterize a More Aggressive Disease 2010 Alberto Rocci; Manuela Gambella; Simona Aschero; Ileana Baldi; Livio Trusolino; Federica Cavallo; Alessandra Larocca; Paola Omedè; Andrea Bertotti; Vittorio Montefusco; Claudia Crippa; Francesca Patriarca; Anna Marina Liberati; Antonietta Falcone; Gianluca Isaia; Daniela Drandi; Marco Ladetto; Paolo M. Comoglio; Giovannino Ciccone; Mario Boccadoro; and Antonio Palumbo
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients. 2010 Bringhen S;Larocca A;Rossi D;Cavalli M;Genuardi M;Ria R;Gentili S;Patriarca F;Nozzoli C;Levi A;Guglielmelli T;Benevolo G;Callea V;Rizzo V;Cangialosi C;Musto P;De Rosa L;Liberati AM;Grasso M;Falcone AP;Evangelista A;Cavo M;Gaidano G;Boccadoro M;Palumbo A
A PROSPECTIVE RANDOMIZED TRIAL OF BORTEZOMIB-MELPHALANPREDNISONE-THALIDOMIDE FOLLOWED BY CONTINUOUS BORTEZOMIB-THALIDOMIDE FOR INITIAL THERAPY OF MULTIPLE MYELOMA:EFFECT OF AGE AND CO-MORBIDITIES 2010 A Palumbo; S Bringhen; D Rossi; M Cavalli; R Ria; M Offidani; C Nozzoli; L Baldini; L De Rosa; G De Sabbata; AM Liberati; C Crippa; F Ciambelli; V Callea; M Spriano; F Ferrara; F Elice; M Galli; J Peccatori; L Catalano; M Rizzo; R Marasca; F Pisani; M Cavo; M Petrucci; P Musto; P Omedè; A Larocca; G Gaidano; M Boccadoro
Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial. 2010 Palumbo A; Bringhen S; Rossi D; Cavalli M; Larocca A; Ria R; Offidani M; Patriarca F; Nozzoli C; Guglielmelli T; Benevolo G; Callea V; Baldini L; Morabito F; Grasso M; Leonardi G; Rizzo M; Pia Falcone A; Gottardi D; Montefusco V; Musto P; Petrucci MT; Ciccone G; Boccadoro M.
Melphalan, prednisone, and thalidomide versus thalidomide, dexamethasone, and pegylated liposomal doxorubicin regimen in very elderly patients with multiple myeloma: a case-match study. 2010 Offidani M; Leoni P; Bringhen S; Corvatta L; Larocca A; Gentili S; Oliva S; Polloni C; Galieni P; Catarini M; Alesiani F; Mele A; Brunori M; Blasi N; Ferranti M; Visani G; Boccadoro M; Palumbo A.
Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial 2010 Palumbo A, Larocca A, Genuardi M, Kotwica K, Gay F, Rossi D, Benevolo G, Magarotto V, Cavallo F, Bringhen S, Rus C, Masini L, Iacobelli M, Gaidano G, Mitsiades C, Anderson K, Boccadoro M, Richardson P; Italian Multiple Myeloma Network GIMEMA.
The efficacy and safety of bortezomib and dexamethasone as a maintenance therapy in patients with advanced multiple myeloma who are responsive to salvage bortezomib-containing regimens 2011 Benevolo G; Larocca A; Gentile M; Pregno P; Gay F; Botto B; Frairia C; Evangelista A; Morabito F; Boccadoro M; Vitolo U; Palumbo A.
A PHASE III STUDY OF ENOXAPARIN VS ASPIRIN AS THROMBOPROPHYLAXIS FOR PATIENTS WITH NEWLY DIAGNOSED OF MULTIPLE MYELOMA TREATED WITH LENALIDOMIDE-BASED REGIMENS. 2011 F. CAVALLO; T. CARAVITA; F. DI RAIMONDO; G. CICCONE; B. LUPO; M. MARCATTI; A. BARALDI; N. PESCOSTA; A.P. FALCONE ;R. RIA; L. BALDINI; L. MASINI; T. GUGLIELMELLI; G. GAIDANO; G. BENEVOLO; C. CANGIALOSI ; M. GALLI ; L. CATALANO; A. LAROCCA; A. NAGLER; M. BOCCADORO; A. PALUMBO
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients. 2011 Gay F; Larocca A; Wijermans P; Cavallo F; Rossi D; Schaafsma R; Genuardi M; Romano A; Liberati AM; Siniscalchi A; Petrucci MT; Nozzoli C; Patriarca F; Offidani M; Ria R; Omedè P; Bruno B; Passera R; Musto P; Boccadoro M; Sonneveld P; Palumbo A.
Evolving paradigms in the treatment of newly diagnosed multiple myeloma. 2011 Larocca A;Palumbo A
Mostrati risultati da 1 a 20 di 108
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile